Unknown

Dataset Information

0

Antimicrobial Activity of Quinoline-Based Hydroxyimidazolium Hybrids.


ABSTRACT: Eight quinoline-based hydroxyimidazolium hybrids 7a-h were prepared and evaluated in vitro against a panel of clinically important fungal and bacterial pathogens, including mycobacteria. Hybrid compounds 7c-d showed remarkable antifungal activity against Cryptococcus neoformans with a minimum inhibitory concentration (MIC) value of 15.6 µg/mL. Against other opportunistic fungi such as Candida spp. and Aspergillus spp., these hybrids showed MIC values of 62.5 µg/mL. Regarding their antibacterial activity, all the synthetic hybrids demonstrated little inhibition of Gram-negative bacteria (MIC ?50 µg/mL), however, hybrid 7b displayed >50% inhibition against Klebsiella pneumoniae at 20 µg/mL and full inhibition at 50 µg/mL. Moreover, this hybrid was shown to be a potent anti-staphylococcal molecule, with a MIC value of 2 µg/mL (5 µM). In addition, hybrid 7h also demonstrated inhibition of Staphylococcus aureus at 20 µg/mL (47 µM). Hybrids 7a and 7b were the most potent against Mycobacterium tuberculosis H37Rv with MIC values of 20 and 10 µg/mL (46 and 24 µM), respectively. The 7b hybrid demonstrated high selectivity in killing S. aureus and M. tuberculosis H37Rv in comparison with mammalian cells (SI >20), and thus it can be considered a hit molecule for mechanism of action studies and the exploration of related chemical space.

SUBMITTER: Insuasty D 

PROVIDER: S-EPMC6963836 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antimicrobial Activity of Quinoline-Based Hydroxyimidazolium Hybrids.

Insuasty Daniel D   Vidal Oscar O   Bernal Anthony A   Marquez Edgar E   Guzman Juan J   Insuasty Braulio B   Quiroga Jairo J   Svetaz Laura L   Zacchino Susana S   Puerto Gloria G   Abonia Rodrigo R  

Antibiotics (Basel, Switzerland) 20191128 4


Eight quinoline-based hydroxyimidazolium hybrids <b>7a-h</b> were prepared and evaluated in vitro against a panel of clinically important fungal and bacterial pathogens, including mycobacteria. Hybrid compounds <b>7c-d</b> showed remarkable antifungal activity against <i>Cryptococcus neoformans</i> with a minimum inhibitory concentration (MIC) value of 15.6 µg/mL. Against other opportunistic fungi such as <i>Candida</i> spp. and <i>Aspergillus</i> spp., these hybrids showed MIC values of 62.5 µg  ...[more]

Similar Datasets

| S-EPMC7179629 | biostudies-literature
| S-EPMC3598976 | biostudies-literature
| S-EPMC8272121 | biostudies-literature
| S-EPMC6931042 | biostudies-literature
| S-EPMC10660482 | biostudies-literature
| S-EPMC6720848 | biostudies-literature
| S-EPMC5687011 | biostudies-literature
| S-EPMC7540715 | biostudies-literature
| S-EPMC8560884 | biostudies-literature
| S-EPMC6009859 | biostudies-literature